4.2% Sodium Bicarbonate Injection recall: Particulate Matter
4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit of Use Syringe, For Intravenous Use, Rx Only, 10 mL Syringe per…
Why was 4.2% Sodium Bicarbonate Injection recalled?
Presence of Particulate Matter; identified as glass
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot GX1542, Exp. 01/01/2025
- Product
- 4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit of Use Syringe, For Intravenous Use, Rx Only, 10 mL Syringe per…
- Recalling firm
- Pfizer Inc.
- Quantity
- 34000 Cartons
- Distribution
- Nationwide in the USA and Puerto Rico.
- Recall date
- January 24, 2024
- Classification
- Class I
- Status
- Ongoing
- Agency
- FDA (drug)